HSD and its compound in drug-containing serum protected the BBB in AD mice, the underlying mechanism of which may be related to inhibit the levels of FG and interact on glia cells in the brain, and by modulating the structure of intestinal microbiota and improving the blood–brain barrier function (Fig. 10). Here, CHST3 is linked to Alzheimer disease.